| Part B: Supplementary Information Sheet (SIS) |
|
FR Recognition List Number
|
057
|
Date of Entry 12/20/2021
|
|
FR Recognition Number
|
19-43
|
| Standard | |
IEC 61326-2-6 Edition 3.0 2020-10
Electrical equipment for measurement, control and laboratory use - EMC requirements - Part 2-6: Particular requirements - In vitro diagnostic (IVD) medical equipment |
|
Scope/Abstract| In addition to the scope of IEC 61326-1, this part of IEC 61326 specifies minimum requirements for immunity and emissions regarding electromagnetic compatibility for IN VITRO DIAGNOSTIC (IVD) MEDICAL EQUIPMENT, taking into account the particularities and specific aspects of this electrical equipment and their electromagnetic environment. |
|
Extent of Recognition
| Partial recognition. The following part(s) of the standard is (are) not recognized: |
Clause 3 Terms, Definitions and Abbreviations
Clause 5.3.101 Operational conditions
Clause 6 Immunity Requirements
Clause 9 Instructions for Use |
|
Rationale for Recognition
This standard is relevant to medical devices and is recognized on its scientific and technical merit and/or because it supports existing regulatory policies.
This standard is recognized in part (or is not recognized at all) because:
1. Clause 3 (Terms, Definitions and Abbreviations) is in conflict with another recognized standard, see Clause 3 Terms and Definitions in standard #1 listed below.
2. Clause 5.3.101 (Operational conditions) is in conflict with existing published final guidance, see Section II "Information to Support a Claim of Electromagnetic Compatibility (EMC) of Electrically-Powered Medical Devices", D, E and F of the guidance #2 listed below.
3. Clause 6 (Immunity Requirements) is in conflict with another recognized standard, see Clause 8 and Annex A in standard #1; recall #3; references #5 , #6 listed below. Alternative acceptance criteria and test levels for immunity tests in the referenced standard #1 can be considered for this clause.
4. Clause 9 (Instructions for Use) is in conflict with existing published final guidance, see Section II, I of the guidance #2 and regulation #4 listed below. |
|
Relevant FDA Guidance and/or Supportive Publications*
1. IEC 60601-1-2 Edition 4.1 2020-09 CONSOLIDATED VERSION Medical electrical equipment - Part 1-2: General requirements for basic safety and essential performance - Collateral Standard: Electromagnetic disturbances - Requirements and tests (Recognition Number: 19-36).
2. Guidance for Industry and Food and Drug Administration Staff: Information to Support a Claim of Electromagnetic Compatibility (EMC) of Electrically2-Powered Medical Devices, Issued July 2016.
3. U.S. Food and Drug Administration, "Class 2 Device Recall Afinion 2, Afinion AS100 Analyzer," 2020.
[Online]. Available: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id=180494. [Accessed: 29-Apr-2021].
4. 21 CFR 809.10 Labeling for in vitro diagnostic products.
5. M. Kohani and M. Pecht, "Malfunctions of medical devices due to electrostatic occurrences big data analysis of 10 years of the FDA's reports," IEEE Access, vol. 6, pp. 5805-5811, 2018.
6. Kohani, Mehdi & Kinslow, Lane & Bhandare, Aniket & Guan, Li & Zhou, Jianchi & Spencer, Christopher & Pecht, Michael. (2019). Electrostatic Charging of a Human Body Caused by Activities and Material Combinations in Hospitals. IEEE Transactions on Electromagnetic Compatibility. PP. 1-9.10.1109/TEMC.2019.2914114.
Appropriate Use of Voluntary Consensus Standards in Premarket Submissions for Medical Devices - Guidance for Industry and Food and Drug Administration Staff, issued September 2018. |
|
| FDA Technical Contact
|
| Standards Development Organization
|
| FDA Specialty Task Group (STG)
|
| *These are provided as examples and others may be applicable. |
|
|
